951 Serum Leucine-Rich-Α-2 Glycoprotein Is a Biomarker for the Effectiveness of Biologic Therapies in Psoriasis

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.963
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PSS14 Cost-Effectiveness of Biologic Therapies for the Treatment of Moderate to Severe Psoriasis in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Serum TSLP Is a Potential Biomarker of Psoriasis Vulgaris Activity

Psoriasis: Targets and Therapy
DermatologyRheumatology
2019English

Zinc-Α-2-Glycoprotein: A Candidate Biomarker for Colon Cancer Diagnosis in Chinese Population

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2014English

Risk of Cancer in Patients With Psoriasis on Biologic Therapies: A Systematic Review

British Journal of Dermatology
DermatologyMedicine
2017English

Cloning of the Alpha Chain of Human Platelet Glycoprotein Ib: A Transmembrane Protein With Homology to Leucine-Rich Alpha 2-Glycoprotein.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1987English

Biologic Therapies in HIV-infected Patients With Psoriasis: An Italian Experience

Acta Dermato-Venereologica
DermatologyMedicine
2017English

Overexpression of Leucine-Rich Α2-Glycoprotein-1 Is a Prognostic Marker and Enhances Tumor Migration in Gastric Cancer

Cancer Science
Cancer ResearchMedicineOncology
2017English

Histidine-Rich Glycoprotein as an Excellent Biomarker for Sepsis and Beyond

Critical Care
Critical CareIntensive Care Medicine
2018English

Treatment Persistence in Psoriasis Patients Initiated on Apremilast, Oral Systemics, or Biologic Therapies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy